Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in High-Grade Glioma Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on High-Grade Glioma 36
Nov 08, 2019: Tocagen highlights Toca 6 phase 1b data at Society for Immunotherapy of Cancer Annual Meeting 36
Clinical Trial Profile Snapshots 37
Appendix 273
Abbreviations 273
Definitions 273
Research Methodology 274
Secondary Research 274
About GlobalData 275
Contact Us 275
Disclaimer 275
Source 276
High-Grade Glioma Therapeutics, Global, Clinical Trials by Region, 2019* 8
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 15
High-Grade Glioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2019* 17
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2019* 21
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase, 2019* 24
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30
High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
List of Figures
High-Grade Glioma Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 15
High-Grade Glioma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2019* 17
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2019* 21
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30
High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33
High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 274
【免責事項】
https://www.marketreport.jp/reports-disclaimer